Francis Tally and the Discovery and Development of Tigecycline: A Personal ReminiscencePROJAN, Steven J.Clinical infectious diseases. 2010, Vol 50, issn 1058-4838, S24-S25, SUP1Conference Paper

Efficacy and safety of tigecycline for the treatment of infectious diseases: a meta-analysisTASINA, Efthimia; HAIDICH, Anna-Bettina; KOKKALI, Stamatia et al.Lancet. Infectious diseases (print). 2011, Vol 11, Num 11, pp 834-844, issn 1473-3099, 11 p.Article

Off-label prescription of tigecycline: clinical and microbiological characteristics and outcomesCONDE-ESTEVEZ, David; GRAU, Santiago; PABLO HORCAJADA, Juan et al.International journal of antimicrobial agents (Print). 2010, Vol 36, Num 5, pp 471-472, issn 0924-8579, 2 p.Article

High Concentrations of Manganese in Mueller-Hinton Agar Increase MICs of Tigecycline Determined by EtestFERNANDEZ-MAZARRASA, Carlos; MAZARRASA, Olav; CALVO, Jorge et al.Journal of clinical microbiology (Print). 2009, Vol 47, Num 3, pp 827-829, issn 0095-1137, 3 p.Article

The in vitro evaluation of tigecycline tested against pathogens isolated in eight countries in the Asia-Western Pacific region (2008)FARRELL, David J; TURNIDGE, John D; BELL, Jan et al.The Journal of infection. 2010, Vol 60, Num 6, pp 440-451, issn 0163-4453, 12 p.Article

Clinical Pharmacokinetics and Pharmacodynamics of TigecyclineBARBOUR, April; SCHMIDT, Stephan; MA, Benjamin et al.Clinical pharmacokinetics. 2009, Vol 48, Num 9, pp 575-584, issn 0312-5963, 10 p.Article

Excess Deaths Associated With Tigecycline After Approval Based on Noninferiority TrialsPRASAD, Paritosh; JUNFENG SUN; DANNER, Robert L et al.Clinical infectious diseases. 2012, Vol 54, Num 12, pp 1699-1709, issn 1058-4838, 11 p.Article

Antimalarial Activity of Tigecycline, a Novel Glycylcycline AntibioticSTARZENGRUBER, P; THRIEMER, K; HAQUE, R et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 9, pp 4040-4042, issn 0066-4804, 3 p.Article

Impact of Different Factors on the Probability of Clinical Response in Tigecycline-Treated Patients with Intra-Abdominal InfectionsBHAVNANI, S. M; RUBINO, C. M; AMBROSE, P. G et al.Antimicrobial agents and chemotherapy. 2010, Vol 54, Num 3, pp 1207-1212, issn 0066-4804, 6 p.Article

Postantibiotic Effect of Tigecycline against 14 Gram-Positive OrganismsPANKUCH, G. A; APPELBAUM, P. C.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 2, pp 782-784, issn 0066-4804, 3 p.Article

Comparative Evaluation of Tigecycline Susceptibility Testing Methods for Expanded-Spectrum Cephalosporin- and Carbapenem-Resistant Gram-Negative PathogensZARKOTOU, Olympia; POURNARAS, Spyros; ALTOUVAS, George et al.Journal of clinical microbiology (Print). 2012, Vol 50, Num 11, pp 3747-3750, issn 0095-1137, 4 p.Article

Trends in the Susceptibility of Clinically Important Resistant Bacteria to Tigecycline: Results from the Tigecycline In Vitro Surveillance in Taiwan Study, 2006 to 2010CHEN, Yen-Hsu; LU, Po-Liang; JANG, Tsrang-Neng et al.Antimicrobial agents and chemotherapy. 2012, Vol 56, Num 3, pp 1452-1457, issn 0066-4804, 6 p.Article

Differences in Determining In Vitro Tigecycline Susceptibility According to the Agar Medium UsedLEAL, A. L; BUITRAGO, G; OVALLE, M. V et al.Journal of chemotherapy (Testo stampato). 2010, Vol 22, Num 2, pp 137-138, issn 1120-009X, 2 p.Article

Evaluation of Etest To Determine Tigecycline MICs for Enterobacter SpeciesCOHEN STUART, James; MOUTON, Johan W; DIEDEREN, Bram M. W et al.Antimicrobial agents and chemotherapy. 2010, Vol 54, Num 6, pp 2746-2747, issn 0066-4804, 2 p.Article

Variation in Potency and Spectrum of Tigecycline Activity against Bacterial Strains from U.S. Medical Centers since Its Approval for Clinical Use (2006 to 2012)SADER, Helio S; FARRELL, David J; FLAMM, Robert K et al.Antimicrobial agents and chemotherapy. 2014, Vol 58, Num 4, pp 2274-2280, issn 0066-4804, 7 p.Article

AdeRS combination codes differentiate the response to efflux pump inhibitors in tigecycline-resistant isolates of extensively drug-resistant Acinetobacter baumanniiSUN, J.-R; PERNG, C.-L; LIN, J.-C et al.European journal of clinical microbiology & infectious diseases (Print). 2014, Vol 33, Num 12, pp 2141-2147, issn 0934-9723, 7 p.Article

Ineffectiveness of Tigecycline against Persistent Borrelia burgdorferiBARTHOLD, Stephen W; HODZIC, Emir; IMAI, Denise M et al.Antimicrobial agents and chemotherapy. 2010, Vol 54, Num 2, pp 643-651, issn 0066-4804, 9 p.Article

Influence of Media and Testing Methodology on Susceptibility to Tigecycline of Enterobacteriaceae with Reported High Tigecycline MICTORRICO, M; GONZALEZ, N; GIMENEZ, M. J et al.Journal of clinical microbiology (Print). 2010, Vol 48, Num 6, pp 2243-2246, issn 0095-1137, 4 p.Article

Minimum inhibitory concentration of carbapenems and tigecycline against Salmonella sppCAPOOR, Malini R; NAIR, Deepthi; POSTI, Jitendra et al.Journal of medical microbiology. 2009, Vol 58, Num 3, pp 337-341, issn 0022-2615, 5 p.Article

Activity of Tigecycline against Coryneform Bacteria of Clinical Interest and Listeria monocytogenesSALAS, Carlos; CALVO, Jorge; MARTINEZ-MARTINEZ, Luis et al.Antimicrobial agents and chemotherapy. 2008, Vol 52, Num 4, pp 1503-1505, issn 0066-4804, 3 p.Article

Susceptibility of common aerobic pathogens to tigecycline : results of a surveillance study in GermanyKRESKEN, M; LEITNER, E; BRAUERS, J et al.European journal of clinical microbiology & infectious diseases (Print). 2009, Vol 28, Num 1, pp 83-90, issn 0934-9723, 8 p.Article

Validation and reproducibility assessment of tigecycline MIC determinations by etestBOLMSTRÖM, Anne; KARLSSON, Asa; ENGELHARDT, Anette et al.Journal of clinical microbiology (Print). 2007, Vol 45, Num 8, pp 2474-2479, issn 0095-1137, 6 p.Article

In vitro activity of tigecycline and comparators against organisms associated with intra-abdominal infections collected as part of TEST (2004―2009)MAYNE, Donna; DOWZICKY, Michael J.Diagnostic microbiology and infectious disease. 2012, Vol 74, Num 2, pp 151-157, issn 0732-8893, 7 p.Article

Tigecycline Resistance Can Occur Independently of the ramA Gene in Klebsiella pneumoniaeVELEBA, Mark; SCHNEIDERS, Thamarai.Antimicrobial agents and chemotherapy. 2012, Vol 56, Num 8, pp 4466-4467, issn 0066-4804, 2 p.Article

Susceptibility of clinical isolates of frequently encountered bacterial species to tigecycline one year after the introduction of this new class of antibiotics: results of the second multicentre surveillance trial in Germany (G-TEST II, 2007)KRESKEN, M; LEITNER, E; SEIFERT, H et al.European journal of clinical microbiology & infectious diseases (Print). 2009, Vol 28, Num 8, pp 1007-1011, issn 0934-9723, 5 p.Article